NBC New York

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.
Monthly Prescribing Reference

Moderna’s mRNA Flu Vaccine Back Under FDA Review

If approved, this would be the first flu vaccine to use the same messenger RNA technology that powered Moderna’s COVID-19 shots. HealthDay News — In a sudden reversal, the US Food and Drug ...
C&EN

‘Regulatory whiplash’ as FDA decides to review Moderna flu shot

The US Food and Drug Administration will now review Moderna’s new, messenger RNA–based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.
Hosted on MSN

FDA reverses course and will now review Moderna’s flu shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s application to sell a new seasonal flu shot after the vaccine maker agreed to conduct additional testing in ...
CNN

FDA reverses course, will review Moderna’s new mRNA flu vaccine

Pirro: I won't recuse myself from WHCD shooting suspect case ...